Investigational Site Number 578003

Oslo

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Type 2 Diabetes

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients — Completed